Skip to content

NeoFitoroid

by Aboca S.P.A. Società Agricola Italy EUDAMED

Ref DEROI2POX/ATROI2POX

EMDN G05

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-ITM29499DEROI2POXK4 Basic UDI-DIDate8 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
DEROI2POX/ATROI2POX
Primary DI / UDI-DI
D-ITM29499DEROI2POXK4
Basic UDI-DI
B-ITM29499DEROI2POXK4
EMDN Code
G05 Topical anorectal administered gastro-intestinal system devices
Device Class
Class IIb
Market of Registration
Germany

Manufacturer details

EUDAMED SRN
IT-MF-000029499

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 1b049918-7fe8-4271-8c4d-942fb41ec42b 61 fields · synced 24 Oct 2026